MYOMO INC (MYO) Fundamental Analysis & Valuation

NYSEARCA:MYO • US62857J2015

Current stock price

0.7249 USD
+0 (+0.51%)
At close:
0.716 USD
-0.01 (-1.23%)
After Hours:

This MYO fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. MYO Profitability Analysis

1.1 Basic Checks

  • In the past year MYO has reported negative net income.
  • MYO had a negative operating cash flow in the past year.
  • MYO had negative earnings in each of the past 5 years.
  • In the past 5 years MYO always reported negative operating cash flow.
MYO Yearly Net Income VS EBIT VS OCF VS FCFMYO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M -10M

1.2 Ratios

  • MYO has a Return On Assets of -35.27%. This is in the lower half of the industry: MYO underperforms 62.50% of its industry peers.
  • MYO has a worse Return On Equity (-82.19%) than 60.33% of its industry peers.
Industry RankSector Rank
ROA -35.27%
ROE -82.19%
ROIC N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
MYO Yearly ROA, ROE, ROICMYO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600

1.3 Margins

  • The Gross Margin of MYO (66.56%) is better than 71.74% of its industry peers.
  • In the last couple of years the Gross Margin of MYO has grown nicely.
  • The Profit Margin and Operating Margin are not available for MYO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 66.56%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
MYO Yearly Profit, Operating, Gross MarginsMYO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

3

2. MYO Health Analysis

2.1 Basic Checks

  • MYO does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • MYO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MYO Yearly Shares OutstandingMYO Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MYO Yearly Total Debt VS Total AssetsMYO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

  • MYO has an Altman-Z score of -3.31. This is a bad value and indicates that MYO is not financially healthy and even has some risk of bankruptcy.
  • MYO has a worse Altman-Z score (-3.31) than 66.30% of its industry peers.
  • A Debt/Equity ratio of 0.23 indicates that MYO is not too dependend on debt financing.
  • MYO has a Debt to Equity ratio of 0.23. This is comparable to the rest of the industry: MYO outperforms 56.52% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Altman-Z -3.31
ROIC/WACCN/A
WACC10.1%
MYO Yearly LT Debt VS Equity VS FCFMYO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M 20M

2.3 Liquidity

  • A Current Ratio of 2.49 indicates that MYO has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.49, MYO is in line with its industry, outperforming 50.00% of the companies in the same industry.
  • A Quick Ratio of 2.10 indicates that MYO has no problem at all paying its short term obligations.
  • The Quick ratio of MYO (2.10) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 2.1
MYO Yearly Current Assets VS Current LiabilitesMYO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. MYO Growth Analysis

3.1 Past

  • The earnings per share for MYO have decreased strongly by -114.71% in the last year.
EPS 1Y (TTM)-114.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.92%

3.2 Future

  • The Earnings Per Share is expected to grow by 27.82% on average over the next years. This is a very strong growth
  • Based on estimates for the next years, MYO will show a very strong growth in Revenue. The Revenue will grow by 21.58% on average per year.
EPS Next Y19.75%
EPS Next 2Y21.99%
EPS Next 3Y29.93%
EPS Next 5Y27.82%
Revenue Next Year17.48%
Revenue Next 2Y19.46%
Revenue Next 3Y22.83%
Revenue Next 5Y21.58%

3.3 Evolution

MYO Yearly Revenue VS EstimatesMYO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 20M 40M 60M 80M 100M
MYO Yearly EPS VS EstimatesMYO Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 -50 -100 -150

More info and screens

Find the best growth stocksShow best growing peers

1

4. MYO Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for MYO. In the last year negative earnings were reported.
  • Also next year MYO is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
MYO Price Earnings VS Forward Price EarningsMYO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
MYO Per share dataMYO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

  • A more expensive valuation may be justified as MYO's earnings are expected to grow with 29.93% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y21.99%
EPS Next 3Y29.93%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. MYO Dividend Analysis

5.1 Amount

  • No dividends for MYO!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

MYO Fundamentals: All Metrics, Ratios and Statistics

MYOMO INC

NYSEARCA:MYO (3/18/2026, 8:26:07 PM)

After market: 0.716 -0.01 (-1.23%)

0.7249

+0 (+0.51%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-09
Earnings (Next)05-05
Inst Owners56.94%
Inst Owner Change-17.69%
Ins Owners7.38%
Ins Owner Change2.34%
Market Cap27.92M
Revenue(TTM)N/A
Net Income(TTM)-12.02M
Analysts80
Price Target5.1 (603.55%)
Short Float %12.89%
Short Ratio8.99
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.37%
Min EPS beat(2)-2.75%
Max EPS beat(2)17.49%
EPS beat(4)2
Avg EPS beat(4)15.25%
Min EPS beat(4)-4.22%
Max EPS beat(4)50.5%
EPS beat(8)4
Avg EPS beat(8)15.32%
EPS beat(12)7
Avg EPS beat(12)15.44%
EPS beat(16)10
Avg EPS beat(16)13.49%
Revenue beat(2)2
Avg Revenue beat(2)5.17%
Min Revenue beat(2)4.48%
Max Revenue beat(2)5.86%
Revenue beat(4)4
Avg Revenue beat(4)9.16%
Min Revenue beat(4)4.48%
Max Revenue beat(4)20.73%
Revenue beat(8)6
Avg Revenue beat(8)5.14%
Revenue beat(12)9
Avg Revenue beat(12)5.57%
Revenue beat(16)12
Avg Revenue beat(16)8.82%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.67
P/FCF N/A
P/OCF N/A
P/B 1.91
P/tB 1.91
EV/EBITDA N/A
EPS(TTM)-0.36
EYN/A
EPS(NY)-0.29
Fwd EYN/A
FCF(TTM)-0.36
FCFYN/A
OCF(TTM)-0.26
OCFYN/A
SpS1.08
BVpS0.38
TBVpS0.38
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -35.27%
ROE -82.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 66.56%
FCFM N/A
ROA(3y)-58.67%
ROA(5y)-62.8%
ROE(3y)-94.75%
ROE(5y)-92.3%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.45%
GM growth 5Y2.49%
F-Score3
Asset Turnover1.22
Health
Industry RankSector Rank
Debt/Equity 0.23
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 782.14%
Cap/Sales 9.22%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.49
Quick Ratio 2.1
Altman-Z -3.31
F-Score3
WACC10.1%
ROIC/WACCN/A
Cap/Depr(3y)269.1%
Cap/Depr(5y)214.88%
Cap/Sales(3y)1.88%
Cap/Sales(5y)1.72%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-114.71%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-750%
EPS Next Y19.75%
EPS Next 2Y21.99%
EPS Next 3Y29.93%
EPS Next 5Y27.82%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-5.92%
Revenue Next Year17.48%
Revenue Next 2Y19.46%
Revenue Next 3Y22.83%
Revenue Next 5Y21.58%
EBIT growth 1Y-41.44%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-79.42%
EBIT Next 3Y-1.11%
EBIT Next 5YN/A
FCF growth 1Y-116.39%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-59.29%
OCF growth 3YN/A
OCF growth 5YN/A

MYOMO INC / MYO Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MYOMO INC?

ChartMill assigns a fundamental rating of 2 / 10 to MYO.


What is the valuation status for MYO stock?

ChartMill assigns a valuation rating of 1 / 10 to MYOMO INC (MYO). This can be considered as Overvalued.


Can you provide the profitability details for MYOMO INC?

MYOMO INC (MYO) has a profitability rating of 1 / 10.


Can you provide the financial health for MYO stock?

The financial health rating of MYOMO INC (MYO) is 3 / 10.